Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
Replimune Inc.
Replimune Inc.
AstraZeneca
Revolution Medicines, Inc.
Marengo Therapeutics, Inc.
Tempus AI
Revolution Medicines, Inc.
Mirai Medical
Celldex Therapeutics
Hoffmann-La Roche
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Mirror Biologics, Inc.
IGF Oncology, LLC
FeRx